öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ººúÏþϼ
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º131

ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺ
ËùÊôԺϵ£º
Ö°³Æ£ºÖ÷ÈÎҽʦ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ¸¾¿ÆÖ×Áö
Ñо¿ÁìÓò£º ¸¾¿ÆÖ×Áö [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºhuxxia@hotmail.com


¸öÈ˼òÊö :
¹¤×÷¾­Àú£º1986Äê7ÔÂÖÁ1995Äê9Ô£¬¹ãÎ÷Çø¸¾Ó×±£½¡Ôº¸¾²ú¿Æ£¬×¡ÔºÒ½Ê¦¡¢Ö÷ÖÎҽʦ 1998ÄêÖÁ½ñ£¬¹ãÎ÷׳×å×ÔÖÎÇøÈËÃñÒ½Ôº¸¾¿Æ£¬¸±Ö÷ÈÎҽʦ¡¢Ö÷ÈÎҽʦ
Éç»áÖ÷Òª¼æÖ°£º¹ãÎ÷ҽѧ»á¸¾¿ÆÖ×Áö·Ö»á ³£Î¯ ¹ãÎ÷¿¹°©Ð­»á¸¾Áö·Ö»á ³£Î¯

¿ÆÑй¤×÷ :
Ö÷Òª¿ÆÑÐÏîÄ¿£º( 2012 Äê1 ÔÂ1 ÈÕ -ÖÁ½ñ) 1. FSTL1µ÷¿ØPI3K/AktÐźÅͨ·ÔÚ¹¬¾±°©Ï¸°ûÔöÖ³ºÍÇÖÏ®ÖеÄ×÷Óü°»úÖÆÑо¿ ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð ÏîÄ¿¸ºÔðÈË ÏîÄ¿Åú×¼ºÅ£º ** 2017.01-2020.12£¬ÔÚÑÐ 2. MiR-31 ºÍMiR-218 Ó빬¾±°©ÁÙ´²Ô¤ºóµÄ¹Øϵ¼°ÔÚ¹¬¾±°©ÇÖϮתÒÆÖеÄ×÷ÓÃÑо¿ ¹ãÎ÷×ÔÈ»¿Æѧ»ù½ð ÏîÄ¿¸ºÔðÈË ÏîÄ¿Åú×¼ºÅ£º2014GXNSFAA118266 2014.06-2017.05 ?ÒÑÉêÇë½áÌâ 3. MiR-218ÔÚ¹¬¾±°©ÇÖϮתÒÆÖеÄ×÷Óü°ÁÙ´²ÒâÒå ¹ãÎ÷ÎÀÉúÊÊÒ˼¼ÊõÑо¿Ó뿪·¢ÏîÄ¿ ±àºÅ£º S201313-01 2013.9£­2016.9 ¾­·Ñ4Íò£¬ÒѽáÌâ 4. MicroRNAÔÚ¹¬¾±°©·¢Éú¹ý³ÌÖеIJîÒìÐÔ±í´ï¼°×÷ÓûúÖÆ ¹ãÎ÷×ÔÈ»¿Æѧ»ù½ðÏîÄ¿¸ºÔðÈË ÏîÄ¿Åú×¼ºÅ£º2011GXNSFC018018 ?2011£­2014 £¬ÒѽáÌâ 5£®MicroRNA ÔÚ¹¬¾±°©¼°°©Ç°²¡±äÖеIJîÒì±í´ï¼°ÔÚ¹¬¾±°©·¢Õ¹¹ý³ÌÖеÄ×÷ÓûúÖÆ£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð ÏîÄ¿¸ºÔðÈË ÏîÄ¿Åú×¼ºÅ£º**£¬ 2011.01-2013.12£¬ ÒѽáÌâ
»ñµÃµÄÖ÷Òª¿ÆÑн±Ï( 2012 Äê1 ÔÂ1 ÈÕ -ÖÁ½ñ) 1.¡¶»ùÖÊøÀàÔÚÂѳ²ÉÏƤ°©½þÈóתÒÆ»úÖƼ°ÁÙ´²Ó¦ÓÃÑо¿¡·»ñ2015Äê¹ãÎ÷Ò½Ò©ÎÀÉúÊÊÒ˼¼ÊõÍƹã¶þµÈ½±£¨ÅÅÃûµÚ¶þ£© 2.¡¶»ùÖÊøÀàÔÚÂѳ²ÉÏƤ°©½þÈóתÒÆ»úÖƼ°ÁÙ´²Ó¦ÓÃÑо¿¡·»ñ2015Äê¹ãÎ÷¿Æ¼¼½ø²½ÈýµÈ½±£¨ÅÅÃûµÚ¶þ£©
Ñо¿ÉúÅàÑø£ºÅàÑø˶ʿÑо¿Éú14Ãû£¬ÒѱÏҵ˶ʿÑо¿Éú9Ãû¡£
½üÄê·¢±í´ú±íÐÔÂÛÎÄ£º( 2014 Äê1 ÔÂ1 ÈÕ -ÖÁ½ñ) 1.? Ôø¿µ¿µ£¬ÕÅ壬ºúÏþϼ £¨Í¨Ñ¶×÷Õߣ©£¬ÄªÏéÀ¼£¬Áõì³£¬À¼½¿.MiR-9¶Ô¹¬¾±°©Ï¸°ûÔöÖ³¡¢Ç¨ÒƼ°ÆäÏÂÓλùÒò±í´ïµÄÓ°Ïì. Öйú¸¾²ú¿ÆÁÙ´²ÔÓÖ¾£¬2014,15£¨1£©:13-16. 2.? Ôø¿µ¿µ£¬ÄªÏéÀ¼£¬Áõ ì³£¬ºúÏþϼ(ͨѶ×÷Õß).¹¬¾±°©¼°°©Ç°²¡±ä×éÖ¯ÖÐmicroRNAsµÄ²îÒì±í´ï.Ö×Áö·ÀÖÎÑо¿,2014,41(7):789-793. 3.? Ö£Îľ² ºúÏþϼ(ͨѶ×÷Õß). MiR-21Ó빬¾±°©¹ØϵÑо¿½øÕ¹. ¹ãÎ÷ҽѧ,2014, 36(4): 484-487. 4.? ºúÏþϼ,Ôø¿µ¿µ,ĪÏéÀ¼ ,Áõì³,Ö£Îľ². miR-218ÔÚ×Ó¹¬¾±°©×éÖ¯Öеıí´ï¼°Ô¤²âµÄ°Ð»ùÒòµÄÉúÎïÐÅϢѧ·ÖÎö.Ö×ÁöÑо¿ÓëÁÙ´²2014, 26(7): 437-441 5.? ÕÅε,Ôø¿µ¿µ,ĪÏéÀ¼,Áõì³,ºúÏþϼ(ͨѶ×÷Õß).miR-9ÔÚ¹¬¾±°©×éÖ¯Öеıí´ï¼°Æä°Ð»ùÒòÔ¤²âºÍÉúÎïÐÅϢѧ·ÖÎö£¬¹ãÎ÷ҽѧ, 2014£¬36(3)£º273-276. 6.? ÕÅε,ÁõÕä,ºúÏþϼ(ͨѶ×÷Õß),Ö£Îľ²,Ôø¿µ¿µ. miRNA-497ÓëmiRNA-195»ùÒò´ØÔÚ¹¬¾±°©×éÖ¯Öеıí´ï¼°Ô¤²â°Ð»ùÒòµÄÉúÎïÐÅϢѧ·ÖÎö.ÖйúÒ½Ò©µ¼±¨,2014,11(31):4-9 7.? ÕÅε,Ö£Îľ²,ºúÏþϼ(ͨѶ×÷Õß).miR-31ÔÚ¹¬¾±°©×éÖ¯Öбí´ï¼°Ô¤²â°Ð»ùÒòµÄÉúÎïÐÅϢѧ·ÖÎö. ÖлªÊµÓÃÕï¶ÏÓëÖÎÁÆÔÓÖ¾,2014,28(5). 8.? Liu W, Gao G£¨Í¬µÈµÚÒ»×÷Õߣ©, Hu X£¨Í¬µÈµÚÒ»×÷Õߣ©, Wang Y, Schwarz JK, Chen JJ, Grigsby PW, Wang X. Activation of miR-9 by human papillomavirus in cervical cancer. Oncotarget. 2014,305(22):11620-30. 9.? Li MY, Hu XX(ͨѶ×÷Õß).Meta-analysis of microRNA expression profiling studies in human cervical cancer.Med Oncol. 2015,32(6):510. 10. D Zeng K, Zheng W, Mo X, Liu F, Li M, Liu Z, Zhang W, Hu X(ͨѶ×÷Õß).Dysregulated microRNAs involved in the progression of cervical neoplasm.Arch Gynecol Obstet. 2015,292(4):905-13. 11. Zheng W, Liu Z, Zhang W, Hu X(ͨѶ×÷Õß).miR-31 functions as an oncogene in cervical cancer.Arch Gynecol Obstet. 2015,292(5):1083-9. 12. ÐíÀòÀò£¬ºúÏþϼ(ͨѶ×÷Õß)£¬ÄªÔÆ£¬ÕÔÈÊ·å.ÉúÓýÆÚ¸¾Å®×Ó¹¬¾±ÉÏƤÄÚÁö±ä¸ßΣÐÍÈËÈéÍ·Áö²¡¶¾¸ÐȾÓëKi-67±í´ïµÄÏà¹ØÐÔ. Öйú¸¾²ú¿ÆÁÙ´²ÔÓÖ¾£¬2015£¬16£¨6£©£º498. 13. ÁõÕ䣬ÕÅ壬ºúÏþϼ(ͨѶ×÷Õß)£¬À¶½¿£¬Ð¤Èðƽ£¬³Âè´£¬ÍõÁÕÁÕ.microRNA-218¶Ô¹¬¾±°©Ï¸°ûÔöÖ³ºÍǨÒƵÄÓ°Ïì.ÖлªÖ×Áö·ÀÖÎÔÓÖ¾,2015,22(20):1602-1608. 14. ÕÅε,ÁõÕä,ºúÏþϼ.΢СºËÌǺËËá-218Ïà¹ØÖ×Áö°Ð»ùÒòµÄÑо¿½øÕ¹.¹ãÎ÷ҽѧ,2015,37(10):1457-1460 15. Meiyi Li, Xiaoxia Hu(ͨѶ×÷Õß), Jianhong Zhong, Lulu Chen,Yongxiu Lin. Therapeutic role of systematic lymphadenectomy in early-stage endometrial cancer: A systematic review. Oncol Lett. 2016 ,11(6):3849-57 16.?? ÕÅε,ÁõÕä,ºúÏþϼ(ͨѶ×÷Õß),ÁÖÓ¾Ðã,ÀîÃÀÒâ,ÍõÁÕÁÕ.¹¬¾±°©ÖÐÒì³£±í´ïmicroRNAÓëHPV-16 E6/E7»ùÒòÏà¹ØÐÔ·ÖÎö. ÖлªÊµÓÃÕï¶ÏÓëÖÎÁÆÔÓÖ¾£¬2016£¬30£¨2£©:120-123 17.?? ÕÅε,ëÁÖ(×ÛÊö),ºúÏþϼ(ÉóУ) .lncRNA HOTAIRÔÚ¸¾¿Æ¶ñÐÔÖ×ÁöÖеÄÑо¿½øÕ¹. ÏÖ´ú¸¾²ú¿Æ½øÕ¹,2016, ?25(7):546-548 18. ÀîÃÀÒâ ºúÏþϼ ÁÖÓ¾Ðã ëÁÖ. ×Ó¹¬ÄÚĤÓëÂѳ²Ô­·¢ÐÔË«°©µÄÁÙ´²Ô¤ºó·ÖÎö.Öйú¸¾²ú¿ÆÁÙ´²ÔÓÖ¾, 2017,18(10):23-25

½ÌÓý±³¾° :
1986Äê±ÏÒµÓÚ¹ãÎ÷ҽѧԺ£¬»ñҽѧѧʿѧλ£»1998Äê±ÏÒµÓÚ¹ãÎ÷Ò½¿Æ´óѧ£¬»ñ¸¾²ú¿Æѧ˶ʿѧλ£»1998Äê±ÏÒµÓÚ¹ãÎ÷Ò½¿Æ´óѧ£¬»ñÖ×Áöѧ²©Ê¿Ñ§Î»£»2007Äê4ÔÂÖÁ2009Äê6Ô£¬ÃÀ¹úʥ·Ò×˹»ªÊ¢¶Ù´óѧҽѧԺ,²©Ê¿ºó